Hypertension Clinical Trial
— RDNOfficial title:
ConfidenHTTM System Safety and Performance of Diagnostic Electrical Mapping of Renal Nerves in Hypertensive Patients and/or Potential Candidates for a Renal Sympathetic Denervation (RDN) Procedure
Verified date | December 2017 |
Source | Rainbow Medical |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To evaluate the safety and performance of the ConfidenHT System
Status | Completed |
Enrollment | 20 |
Est. completion date | December 2017 |
Est. primary completion date | November 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: 1. Signed written informed consent. 2. Age >18 years and <75. 3. Either: 1. Hypertensive patients planned to undergo elective cardiac catheterization 2. Potential candidates for renal sympathetic denervation 4. Main renal artery with diameter = 4.0mm. 5. Glomerular Filtration Rate (GFR) >45 mL/min 6. A patient who is mentally competent with the ability to understand and comply with the requirements of the study. 7. The patient agrees to attend all follow-up evaluations and is willing to complete required exams and tests. 8. Female patients with childbearing potential must agree: - to use a valid method of contraception (oral contraceptives, intrauterine device, subcutaneous contraceptive implant, vaginal ring) - to perform a pregnancy test Exclusion criteria: 1. Previous participation in another study with any investigational drug or device within the past 30 days. 2. Relevant renal artery disease (% diameter stenosis>30%, aneurysm or fibromuscular dysplasia). 3. Known secondary causes of hypertension. 4. The patient has a life expectancy = 12 months. 5. The patient has undergone prior renal denervation, renal stenting, and/or abdominal aortic stent grafts. 6. The patient has chronic oxygen use other than nocturnal support for sleep apnea. 7. The patient has type I diabetes mellitus. 8. The patient has had a previous organ transplant or is awaiting a renal transplant. 9. Active implantable medical device (e.g. ICD or CRT-D; neuromodulator/spinal stimulator; baroreflex stimulator). 10. The patient has triple ipsilateral artery ostia. 11. Moderate to severe valvular heart disease. 12. The patient has other concomitant conditions that may adversely affect the patient or the study outcome. 13. Female who is pregnant, nursing or planning to become pregnant. 14. Documented contraindication or allergy to contrast medium not amenable to treatment. |
Country | Name | City | State |
---|---|---|---|
Greece | Hippocratio Hospital | Athens | |
Netherlands | EMC | Rotterdam | |
Netherlands | UMC | Utrecht |
Lead Sponsor | Collaborator |
---|---|
Rainbow Medical |
Greece, Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The incidence of serious adverse events (system and/or procedure related events) | The incidence of serious adverse events (system and/or procedure related events) | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |